Jia-Hua Ding

Author PubWeight™ 8.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation. Chin J Cancer 2010 0.97
2 [Preparation of Fe3O4-magnetic nanoparticles loaded with adriamycin and its reversal of multidrug resistance in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.93
3 Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells. Int J Nanomedicine 2008 0.92
4 Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.81
5 Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin. Biol Blood Marrow Transplant 2011 0.81
6 Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia. Chin Med J (Engl) 2012 0.80
7 Effects of magnetic nanoparticle of Fe3O4 on apoptosis induced by Gambogic acid in U937 leukemia cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.77
8 [A new method for 5, 10-methylenetetrahydrofolate reductase single nucleotide polymorphisms genotyping used to study susceptibility of hematological malignancy]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.77
9 [Reversal effect of gambogic acid on multidrug resistance of K562/A02 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012 0.76
10 An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitution. PLoS One 2013 0.75
11 [Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
12 [Auto-hematopoietic stem cell transplantation for multiple myeloma accompanied with amyloidosis in four limbs]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
13 [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011 0.75
14 [Effect of gambogic acid on proliferation of SKM-1 cells and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013 0.75
15 [Apoptosis of human myelodysplastic syndrome cell Line MUTZ-1 induced by sodium valproate]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
16 [Inhibition effect of gambogic acid on MUTZ-1 cell line and its possible mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
17 [Effect of tetrandrine in combination with droloxifen on the expression of NF-kappaB protein in K562 and K562/A02 cell lines]. Zhonghua Xue Ye Xue Za Zhi 2008 0.75
18 [Purging effects of CD3AK/iNOS in vitro on primary leukemic cells from chronic myeloid leukemia patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005 0.75
19 [Enhancement of reversing drug resistance of K562/A02 cells to adriamycin by ultrasound-induced cavitation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
20 [Gene expression in patients with myelodysplastic syndrome]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
21 Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia. Am J Nephrol 2007 0.75
22 [Construction and identification of Mdr-1-shRNA eukaryotic expression vector]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
23 [Establishment of cytokine-independent human myelodysplastic cell line and its characteristics]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005 0.75
24 [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011 0.75
25 [Test of activated plasma clotting time to assess efficacy of platelet transfusion]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
26 [Effect of hematopoietic stem cell transplantation in malignant hematologic disease of lymphatic system]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
27 [Clinical application of BCR/ABL probes in myeloproliferative disorders]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013 0.75
28 [Analysis of hematopoietic chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
29 [Alterations of telomerase activity and apoptosis induced by 2-methoxyestradiol in human myelodysplastic syndrome cell line MUTZ-1]. Zhonghua Xue Ye Xue Za Zhi 2007 0.75
30 [Detection of bcr-abl fusion gene mRNA level in K562/A02 cell line by real-time quantitative RT-PCR]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011 0.75
31 [Effect of Autologous or Allogeneic Anti-CD3 Monoclonal Antibody Activated Killer Cells on Normal Hematopoietic Cells] Zhongguo Shi Yan Xue Ye Xue Za Zhi 2001 0.75
32 [Sodium valproate synergizes adriamycin to inhibit proliferation and induce apoptosis in myelodysplastic syndrome cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
33 [Study on reversal effect of nilotinib in combination with 5-BrTet on multidrug resistance of K562/A02 cell line]. Zhonghua Xue Ye Xue Za Zhi 2010 0.75
34 [Detection of single nucleotide polymorphisms of Jak2 gene in multiple myeloma by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
35 Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
36 [Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line]. Zhonghua Xue Ye Xue Za Zhi 2010 0.75
37 [Protective effects of amifostine on hematopoietic stem/progenitor cells against chemotherapeutic damage]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004 0.75
38 [Effects of platelet-derived membrane microparticles on the proliferation and apoptosis of human umbilical vein endothelial cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
39 [Effects of platelet-derived membrane microparticles on angiogenesis in chick chorioallantoic membranes]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
40 [Effect of desferrioxamine on K562/A02 cell line and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011 0.75
41 [Effect of tetrandrine combined with daunorubicin on expressions of P21 and P-gp in K562/A02 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
42 [Platelet-derived microparticles stimulate proliferation of granulocyte-macrophage progenitor cells from umbilical cord blood]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
43 [Advance of research on survivin in hematological malignancies--review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004 0.75
44 [Regulation of 2-methoxyestradiol-induced cell apoptosis by mcl-1 and bax genes in myelodysplastic syndrome]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
45 [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
46 [Inhibition effect of vitamin K2 on human MDS-JSN04 cell line and its possible mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005 0.75
47 [Effect of cyclosporine A, raloxifene and their combination on the reversion of multidrug resistance of K562/A02 line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
48 MDR reversal activity of bromotetrandrine in vitro and in vivo. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
49 Effects of magnetic nanoparticle of fe(3)o(4) and 5-bromotetrandrine on apoptosis of K562/A02 leukemic cells induced by daunorubicin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
50 [Possible mechanism underlying apoptotic induction effect of vitamin K2 on human MDS cell line MUTZ-1]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
51 [Effects of sensitized donor lymphocyte infusion on the chimerism and graft-versus-host disease after nonmyeloablative allogeneic stem cell transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
52 [Cold storage of rabbit platelet suspension by adding uridine diphosphate galactose]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 0.75
53 [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
54 [Effect of sodium valproate on human myelodysplastic syndrome cell line SKM-1 and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
55 [Influence of magnetic Fe3O4 nanoparticle on functions of lymphocytes and macrophages in mice]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75
56 [Induction of immune tolerance for allogenic recipient mice by non-myeloablative bone marrow transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005 0.75
57 [Phenylhexyl isothiocyanate reducing U266 cell line methylation level of p16 gene]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
58 [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 0.75
59 [Effect of recipient mouse splenocytes taken orally by donor mouse on GVHD after splenocyte transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
60 [Effects of advanced glycosylation end products and tetrandrine on proliferation of K562 and K562/A02 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012 0.75
61 [Selective elimination of alloreactive donor lymphocytes by using TBI and cyclophosphamide]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007 0.75
62 [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 0.75
63 [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010 0.75